Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
Clinical trial NCT05969041 · RECRUITING
Trial details
- NCT number
- NCT05969041
- Sponsor
- Myeloid Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-02
- Primary completion
- 2027-08-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.